Navigating precision: the crucial role of next-generation sequencing recurrence risk assessment in tailoring adjuvant therapy for hormone receptor-positive, human epidermal growth factor Receptor2-negative early breast cancer - Xu, Y; Qi, Y; Lu, Z (Cancer Biol Ther, 2024)